Category Archives: Health Care Services

Electrocardiograph (ECG) Market to Reckon increasing valuation $6,637 Million by 2023

“Recent technological advancements in ECG devices with enhanced features such as mobile ECG devices with a wireless system that can transmit data to monitoring stations, and improved detection rates boost the ECG market growth. In addition, increase in awareness regarding preventive healthcare among people increased the frequency of electrocardiography thereby propelling the market growth.”

According to a new report published by Allied Market Research, titled, Electrocardiograph (ECG) Market by Product, Lead Type and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global electrocardiograph market was valued at $4,516 million in 2016, and is projected to reach $6,637 million by 2023, growing at a CAGR of 5.6% from 2017 to 2023. The 3-6 lead type ECG accounted for four-ninths share of the global market in 2016.

Atrial Fibrillation Market to Expand at a Modest CAGR of 11.0% by 2022

Atrial fibrillation is becoming common among individuals due to the various factors such as hypertension, high alcohol intake, rising number of people with common diseases such as diabetes and obesity. However, with the growth in atrial fibrillation, the procedures and devices providing diagnoses and treatment are also increasing. Technologically advanced procedures are being adopted by the hospitals and clinics to treat atrial fibrillation. Meanwhile, favorable regulatory steps by the government in various countries is also leading to the rise in adoption of advanced procedures for diagnoses and treatment of atrial fibrillation.

Browse Press Release @

Nitinol Medical Devices Market Opportunity will Rise to US$25,657.5 mn by 2025

Global Nitinol Medical Devices Market: Snapshot

In a consolidated yet competitive global nitinol medical devices market, savvy players are hard-focused on product innovation to strengthen their position. Keen players are also vying to expand their geographical outreach by means of strategic partnerships and mergers and acquisitions.

Majorly fuelling the global nitinol medical devices market is the rising prevalence of cardiovascular diseases, growing geriatric population susceptible to peripheral artery diseases, and increasing demand for minimally invasive surgical procedures. As per statistics of the World Health Organization, almost 17.7 million individuals suffer from cardiovascular diseases each year; cardiovascular diseases account for 31% deaths each year globally.

Membrane Separation Systems Market is Projected to Increment at a Healthy CAGR 9.3% Between 2017 and 2025

Global Membrane Separation Systems Market: Snapshot

The global market for membrane separation systems is gaining from measures taken for water conservation and from adoption of technology for wastewater treatment for the essential commodity to last for successive generations. Municipal agencies and metropolitan planners in several countries are preparing for the impact in the event of water shortage which is an essential commodity. This is pushing the need for innovations in water treatment technologies, which in turn, is stoking demand for membrane separation systems.

Proving to be a roadblock to the growth of this market are high establishment and operational costs, insufficient lack in emerging economies, and availability of alternate technologies for water treatment.

Heparin Market to Expand at a Modest CAGR of 6.2% by 2025

Global Heparin Market: Snapshot

The global heparin market is anticipated to attract growth opportunities on the back of the rising count of surgical procedures and increasing treatment of venous thromboembolism (VTE) including pulmonary embolism (PE) and deep vein thrombosis (DVT). Anticoagulant heparin holds the ability to reduce blood clotting. It could be used in blood transfusion, blood samplings during prophylaxis treatment, and the treatment of blood clotting disorders.

Browse Press Release @

As per the analysis of the report, the global heparin market could expand at a CAGR of 6.2% for the forecast period 2017–2025 to reach a valuation of US$16.3 bn by the end of 2025. In 2017, the market attained a valuation of US$10.1 bn.

Magnetic Resonance Imaging Market Opportunity will Rise to US$9120.8 mn by 2022

Global Magnetic Resonance Imaging Market: Snapshot

The magnetic resonance imaging (MRI) modality has garnered wide popularity for a non-invasive diagnostic imaging of conditions related to orthopedics, spine, neurology, cardiovascular, head and neck, and abdominal and prostate. The marked sensitivity and specificity of this imaging modality has made it a popular choice for the diagnosis of several neurological conditions world over. For instance, the advent of multinuclear spectroscopy to analyze several neurological disorders with the help of high-quality MRI scanner has gained traction in recent years. With no known biological hazard, these modalities are found to be useful for the detection of diseases that manifest themselves by an imbalance of water content in bodies. The use of better imaging contrast agents across ambulatory surgical centers, and diagnostic imaging centers enables advanced imaging with high-resolution, thereby accentuating the market.

Global Activated Carbon Market Expected to Grow at a CAGR of 6.14% by 2022

Global Activated Carbon Market Overview:

Activated carbon is also called as activated charcoal, is a form of porous carbon, without graphite, formed by the activation of carbonaceous materials such as sawdust, bamboo, coconut shells, wood chips, coal, rice leaves, etc. Extruded products are commonly used in the activated carbon market. The impregnated carbon is another variety that contains different elements, such as the carbons coated with polymer, iodine and silver. Activated carbon is used in a wide range of applications in the treatment of gases, vapors and liquids. The active carbon value chain includes raw material suppliers, the production process, product supply channels, end-use industries and after-sales service.

Artificial Heart – A Possibility

The need for total artificial heart devices is growing as life threatening heart diseases are increasing and the number of heart donors is decreasing. Total artificial heart is a medical device that provides mechanical circulatory support and replaces both ventricles of the heart. Companies and medical teams around the world are developing different types of artificial hearts that have been implanted in patients since 1969. Almost all of these artificial hearts are used as a bridge to human heart transplantation. But destination therapy for total artificial heart is under investigation. For instance, FDA approved two artificial hearts manufactured by SynCardia and AbioCor companies. In March 2015, FDA also approved an investigational study for new smaller SynCardia Total Artificial Heart.

Portable Diagnostic Equipment- Yes, They Exist!

Portable diagnostic equipment is expected to be a fast growing segment, and competitors are focusing on developing new and innovative portable equipment during the forecast period. Owing to their ease of use and point-of-care applications, their adoption rates are steadily increasing not only for emergency and intensive care units in hospitals, but also as a part of homecare organizations. There is also a growing need for portable devices in the emergency care units for easy and quick usage, faster interventions for acute events, and better monitoring. Some of the well-known products are Samsung Electronics’ 32-SLICE CT scanner, Brain Biosciences’ CERPET portable PET scanner, Siemens Healthcare’s Mobilett mira max portable X-ray systems and Sonosite’s MicroMaxx portable ultrasound system.

Cytokines Market Emerging Opportunities, Competitive Landscape and Revenue Share 2025

9th November 2018 – Global Cytokines Market is segmented on the basis of type, application, and geography. Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, interferons and chemokines, but can also include other molecules as well.

Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expanded into more disease relevant, specialized panels for a more accurate assessment of various diseases that include cardiovascular disease, asthma, inflammation, cancer, diabetes and rheumatoid arthritis.